Animal Biotechnology Market (By Product Type: Diagnostics Tests, Vaccines, Drugs; By Application; By Animal Type; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Animal Biotechnology Market 

5.1. COVID-19 Landscape: Animal Biotechnology Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Animal Biotechnology Market, By Product Type

8.1. Animal Biotechnology Market, by Product Type, 2022-2030

8.1.1. Diagnostics Tests

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Vaccines

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Drugs

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Reproductive and Genetic

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Feed Additives

8.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Animal Biotechnology Market, By Application

9.1. Animal Biotechnology Market, by Application e, 2022-2030

9.1.1. Diagnosis of Animal Diseases

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Treatment of Animal Diseases

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Preventive Care of Animals

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Drug Development

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Animal Biotechnology Market, By Animal Type 

10.1. Animal Biotechnology Market, by Animal Type, 2022-2030

10.1.1. Companion

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Livestock

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Animal Biotechnology Market, By End-use 

11.1. Animal Biotechnology Market, by End-use, 2022-2030

11.1.1. Laboratories

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Point-of-Care Testing/In-house Testing

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Veterinary Hospitals & Clinics

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Animal Biotechnology Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.1.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.1.4. Market Revenue and Forecast, by End-use (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.1.5.4. Market Revenue and Forecast, by End-use (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.1.6.4. Market Revenue and Forecast, by End-use (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.2.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.2.4. Market Revenue and Forecast, by End-use (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.2.5.4. Market Revenue and Forecast, by End-use (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.2.6.4. Market Revenue and Forecast, by End-use (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.2.7.4. Market Revenue and Forecast, by End-use (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.2.8.4. Market Revenue and Forecast, by End-use (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.3.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.3.4. Market Revenue and Forecast, by End-use (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.3.5.4. Market Revenue and Forecast, by End-use (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.3.6.4. Market Revenue and Forecast, by End-use (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.3.7.4. Market Revenue and Forecast, by End-use (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.3.8.4. Market Revenue and Forecast, by End-use (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.4.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.4.4. Market Revenue and Forecast, by End-use (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.4.5.4. Market Revenue and Forecast, by End-use (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.4.6.4. Market Revenue and Forecast, by End-use (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.4.7.4. Market Revenue and Forecast, by End-use (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.4.8.4. Market Revenue and Forecast, by End-use (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.5.4. Market Revenue and Forecast, by End-use (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.5.5.4. Market Revenue and Forecast, by End-use (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Animal Type (2017-2030)

12.5.6.4. Market Revenue and Forecast, by End-use (2017-2030)

Chapter 13. Company Profiles

13.1. Zoetis

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Boehringer Ingelheim International GmbH

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Biogénesis Bagó

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Merck & Co., Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Virbac

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Elanco

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Idexx Laboratories

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Heska Corporation

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Indian Immunologicals Ltd.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. HESTER BIOSCIENCES LIMITED

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms